Copyright Reports & Markets. All rights reserved.

Global Amphotericin B Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Amphotericin B Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Amphotericin B Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Static Drops
      • 1.4.3 Atomization Inhalation
      • 1.4.4 Local Lesion Injection
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Amphotericin B Market Share by Application: 2020 VS 2026
      • 1.5.2 Vaginitis
      • 1.5.3 Candida Infection
      • 1.5.4 Leishmaniasis
      • 1.5.5 Kala-Azar
      • 1.5.6 Cryptococcal Infection
      • 1.5.7 Aspergillus Infection
      • 1.5.8 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Amphotericin B Market Perspective (2015-2026)
    • 2.2 Amphotericin B Growth Trends by Regions
      • 2.2.1 Amphotericin B Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Amphotericin B Historic Market Share by Regions (2015-2020)
      • 2.2.3 Amphotericin B Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Amphotericin B Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Amphotericin B Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Amphotericin B Players by Market Size
      • 3.1.1 Global Top Amphotericin B Players by Revenue (2015-2020)
      • 3.1.2 Global Amphotericin B Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Amphotericin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Amphotericin B Market Concentration Ratio
      • 3.2.1 Global Amphotericin B Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Amphotericin B Revenue in 2019
    • 3.3 Amphotericin B Key Players Head office and Area Served
    • 3.4 Key Players Amphotericin B Product Solution and Service
    • 3.5 Date of Enter into Amphotericin B Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Amphotericin B Historic Market Size by Type (2015-2020)
    • 4.2 Global Amphotericin B Forecasted Market Size by Type (2021-2026)

    5 Amphotericin B Breakdown Data by Application (2015-2026)

    • 5.1 Global Amphotericin B Market Size by Application (2015-2020)
    • 5.2 Global Amphotericin B Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Amphotericin B Market Size (2015-2020)
    • 6.2 Amphotericin B Key Players in North America (2019-2020)
    • 6.3 North America Amphotericin B Market Size by Type (2015-2020)
    • 6.4 North America Amphotericin B Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Amphotericin B Market Size (2015-2020)
    • 7.2 Amphotericin B Key Players in Europe (2019-2020)
    • 7.3 Europe Amphotericin B Market Size by Type (2015-2020)
    • 7.4 Europe Amphotericin B Market Size by Application (2015-2020)

    8 China

    • 8.1 China Amphotericin B Market Size (2015-2020)
    • 8.2 Amphotericin B Key Players in China (2019-2020)
    • 8.3 China Amphotericin B Market Size by Type (2015-2020)
    • 8.4 China Amphotericin B Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Amphotericin B Market Size (2015-2020)
    • 9.2 Amphotericin B Key Players in Japan (2019-2020)
    • 9.3 Japan Amphotericin B Market Size by Type (2015-2020)
    • 9.4 Japan Amphotericin B Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Amphotericin B Market Size (2015-2020)
    • 10.2 Amphotericin B Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Amphotericin B Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Amphotericin B Market Size by Application (2015-2020)

    11 India

    • 11.1 India Amphotericin B Market Size (2015-2020)
    • 11.2 Amphotericin B Key Players in India (2019-2020)
    • 11.3 India Amphotericin B Market Size by Type (2015-2020)
    • 11.4 India Amphotericin B Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Amphotericin B Market Size (2015-2020)
    • 12.2 Amphotericin B Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Amphotericin B Market Size by Type (2015-2020)
    • 12.4 Central & South America Amphotericin B Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Bristol-Myers Squibb
      • 13.1.1 Bristol-Myers Squibb Company Details
      • 13.1.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
      • 13.1.3 Bristol-Myers Squibb Amphotericin B Introduction
      • 13.1.4 Bristol-Myers Squibb Revenue in Amphotericin B Business (2015-2020))
      • 13.1.5 Bristol-Myers Squibb Recent Development
    • 13.2 Matinas BioPharma
      • 13.2.1 Matinas BioPharma Company Details
      • 13.2.2 Matinas BioPharma Business Overview and Its Total Revenue
      • 13.2.3 Matinas BioPharma Amphotericin B Introduction
      • 13.2.4 Matinas BioPharma Revenue in Amphotericin B Business (2015-2020)
      • 13.2.5 Matinas BioPharma Recent Development
    • 13.3 Nanox
      • 13.3.1 Nanox Company Details
      • 13.3.2 Nanox Business Overview and Its Total Revenue
      • 13.3.3 Nanox Amphotericin B Introduction
      • 13.3.4 Nanox Revenue in Amphotericin B Business (2015-2020)
      • 13.3.5 Nanox Recent Development
    • 13.4 Nanomerics
      • 13.4.1 Nanomerics Company Details
      • 13.4.2 Nanomerics Business Overview and Its Total Revenue
      • 13.4.3 Nanomerics Amphotericin B Introduction
      • 13.4.4 Nanomerics Revenue in Amphotericin B Business (2015-2020)
      • 13.4.5 Nanomerics Recent Development
    • 13.5 DNDi
      • 13.5.1 DNDi Company Details
      • 13.5.2 DNDi Business Overview and Its Total Revenue
      • 13.5.3 DNDi Amphotericin B Introduction
      • 13.5.4 DNDi Revenue in Amphotericin B Business (2015-2020)
      • 13.5.5 DNDi Recent Development
    • 13.6 Abzena
      • 13.6.1 Abzena Company Details
      • 13.6.2 Abzena Business Overview and Its Total Revenue
      • 13.6.3 Abzena Amphotericin B Introduction
      • 13.6.4 Abzena Revenue in Amphotericin B Business (2015-2020)
      • 13.6.5 Abzena Recent Development
    • 13.7 Bharat Serums
      • 13.7.1 Bharat Serums Company Details
      • 13.7.2 Bharat Serums Business Overview and Its Total Revenue
      • 13.7.3 Bharat Serums Amphotericin B Introduction
      • 13.7.4 Bharat Serums Revenue in Amphotericin B Business (2015-2020)
      • 13.7.5 Bharat Serums Recent Development
    • 13.8 Jina Pharma
      • 13.8.1 Jina Pharma Company Details
      • 13.8.2 Jina Pharma Business Overview and Its Total Revenue
      • 13.8.3 Jina Pharma Amphotericin B Introduction
      • 13.8.4 Jina Pharma Revenue in Amphotericin B Business (2015-2020)
      • 13.8.5 Jina Pharma Recent Development
    • 13.9 Astellas Pharma
      • 13.9.1 Astellas Pharma Company Details
      • 13.9.2 Astellas Pharma Business Overview and Its Total Revenue
      • 13.9.3 Astellas Pharma Amphotericin B Introduction
      • 13.9.4 Astellas Pharma Revenue in Amphotericin B Business (2015-2020)
      • 13.9.5 Astellas Pharma Recent Development
    • 13.10 Leadiant Biosciences
      • 13.10.1 Leadiant Biosciences Company Details
      • 13.10.2 Leadiant Biosciences Business Overview and Its Total Revenue
      • 13.10.3 Leadiant Biosciences Amphotericin B Introduction
      • 13.10.4 Leadiant Biosciences Revenue in Amphotericin B Business (2015-2020)
      • 13.10.5 Leadiant Biosciences Recent Development
    • 13.11 Kadmon Corporation (Eli Lilly and Company)
      • 10.11.1 Kadmon Corporation (Eli Lilly and Company) Company Details
      • 10.11.2 Kadmon Corporation (Eli Lilly and Company) Business Overview and Its Total Revenue
      • 10.11.3 Kadmon Corporation (Eli Lilly and Company) Amphotericin B Introduction
      • 10.11.4 Kadmon Corporation (Eli Lilly and Company) Revenue in Amphotericin B Business (2015-2020)
      • 10.11.5 Kadmon Corporation (Eli Lilly and Company) Recent Development
    • 13.12 InterMune
      • 10.12.1 InterMune Company Details
      • 10.12.2 InterMune Business Overview and Its Total Revenue
      • 10.12.3 InterMune Amphotericin B Introduction
      • 10.12.4 InterMune Revenue in Amphotericin B Business (2015-2020)
      • 10.12.5 InterMune Recent Development
    • 13.13 Sterimax Inc
      • 10.13.1 Sterimax Inc Company Details
      • 10.13.2 Sterimax Inc Business Overview and Its Total Revenue
      • 10.13.3 Sterimax Inc Amphotericin B Introduction
      • 10.13.4 Sterimax Inc Revenue in Amphotericin B Business (2015-2020)
      • 10.13.5 Sterimax Inc Recent Development
    • 13.14 X-GEN Pharmaceuticals
      • 10.14.1 X-GEN Pharmaceuticals Company Details
      • 10.14.2 X-GEN Pharmaceuticals Business Overview and Its Total Revenue
      • 10.14.3 X-GEN Pharmaceuticals Amphotericin B Introduction
      • 10.14.4 X-GEN Pharmaceuticals Revenue in Amphotericin B Business (2015-2020)
      • 10.14.5 X-GEN Pharmaceuticals Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Amphotericin B status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amphotericin B development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Bristol-Myers Squibb
      Matinas BioPharma
      Nanox
      Nanomerics
      DNDi
      Abzena
      Bharat Serums
      Jina Pharma
      Astellas Pharma
      Leadiant Biosciences
      Kadmon Corporation (Eli Lilly and Company)
      InterMune
      Sterimax Inc
      X-GEN Pharmaceuticals

      Market segment by Type, the product can be split into
      Static Drops
      Atomization Inhalation
      Local Lesion Injection
      Other
      Market segment by Application, split into
      Vaginitis
      Candida Infection
      Leishmaniasis
      Kala-Azar
      Cryptococcal Infection
      Aspergillus Infection
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Amphotericin B status, future forecast, growth opportunity, key market and key players.
      To present the Amphotericin B development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Amphotericin B are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now